Ra Capital Management, L.P. Selecta Biosciences Inc Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$2.18 - $2.84 $207,100 - $269,800	-95,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.83 - $4.06 $1.42 Million - $3.15 Million	-775,633 Reduced 89.09%	95,000 $270,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.52 $1.31 Million - $3.94 Million	870,633 New	870,633 $2.1 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.